UH
University Hospital Tübingen at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University Hospital Tübingen brings 3 presentations to ESGCT 2026 in Hamburg. Its work spans genome editing, retinal disease and engineered T cells. Topics include compact RNA-guided nucleases built for safer editing, a mutation-agnostic approach to retinitis pigmentosa, and tuning CAR signalling for better T cell function.
| Organization | ESGCT 2026 Attendance |
|---|---|
UH University Hospital Tübingen Tübingen, Germany | |
University hospital in Tübingen, Germany, with research on CAR-T cells and other cancer immunotherapies. | Poster Wed Oct 28 1:30pm–3:30pm AAV-deliverable TREX2-Enhanced small RNA-guided nucleases (EDsRGNs) for Safer Therapeutic Genome Editing Poster Thu Oct 29 2:00pm–4:00pm A mutation-agnostic ASO strategy demonstrates potent functional rescue and retinal preservation in RHO-linked retinitis pigmentosa Talk Thu Oct 29 5:15pm–6:00pm ROADSTAR enables CAR design-specific signaling optimization for improved CAR T cell function Cell therapies and CAR-T |
Instantly find 20 buyers from University Hospital Tübingen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction